ELMD (Electromed) Other Long-Term Liabilities: $0.07 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ELMD Electromed Inc ELMD
94 GF Score
Price $31.77
GF Value $27.26
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Electromed Other Long-Term Liabilities?

Electromed ELMD -19.24% 94 Other Long-Term Liabilities is $0.07 Mil as of Jun. 2026. GuruFocus rates ELMD with a GF Score™ of 94/100 and a GF Value™ of $27.26 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Electromed's other long-term liabilities for the quarter that ended in Jun. 2026 was $0.07 Mil.

Electromed's quarterly other long-term liabilities declined from Dec. 2025 ($0.10 Mil) to Mar. 2026 ($0.08 Mil) and declined from Mar. 2026 ($0.08 Mil) to Jun. 2026 ($0.07 Mil).

Electromed's annual other long-term liabilities increased from Jun. 2024 ($0.01 Mil) to Jun. 2025 ($0.13 Mil) but then declined from Jun. 2025 ($0.13 Mil) to Jun. 2026 ($0.07 Mil).

Electromed Other Long-Term Liabilities Related Terms

Electromed Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Electromed's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electromed Other Long-Term Liabilities Chart

Electromed Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.09 0.01 0.13 0.07

Electromed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.11 0.10 0.08 0.07
ELMD
94GF Score
Electromed Inc ELMD
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Electromed Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $0.07 Mil mean?
Electromed (ELMD) has a Other Long-Term Liabilities of $0.07 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Electromed and its competitors.
Is Electromed's Other Long-Term Liabilities too high?
Electromed's current Other Long-Term Liabilities is $0.07 Mil. Overall, Electromed has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's Other Long-Term Liabilities compare to LAB and CV?
Electromed's Other Long-Term Liabilities of $0.07 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Devices & Instruments company?
A good Other Long-Term Liabilities depends on the Medical Devices & Instruments industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Electromed and its competitors. Electromed's current Other Long-Term Liabilities is $0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $27.26, compared to a current price of $31.77 — trading 16.5% above its estimated fair value. The current Other Long-Term Liabilities is $0.07 Mil. Electromed's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Electromed (ELMD), the current Other Long-Term Liabilities is $0.07 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Electromed (ELMD) Overvalued in 2026?

Based on GuruFocus' analysis, Electromed stock appears to be overvalued. The current stock price of $31.77 is trading 16.5% above its estimated GF Value™ of $27.26. GuruFocus considers Electromed to be Modestly Overvalued.

Key valuation signals for ELMD:

  • Other Long-Term Liabilities: $0.07 Mil
  • GF Value™: $27.26 vs. price of $31.77 (16.5% above fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Electromed Business Description

Address 500 Sixth Avenue NW, New Prague, MN, USA, 56071
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
94GF Score

Get the complete analysis for ELMD

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.77
Price
$27.26
GF Value